Boston Scientific, Surgi-Vision to Develop Cardiac Devices

Boston Scientific Corp. and Surgi-Vision Inc. of Baltimore, Md., announced a deal to license and develop magnetic resonance imaging (MRI)-safe technology for implantable cardiac devices. The companies will jointly develop a commercial application of Surgi-Vision's technology. They made a separate licensing and development agreement, in the area of neuromodulation, in December 2005.





LATEST NEWS

• STEMMER IMAGING Receives Takeover Bid
  Jul 23, 2024
• Nanofabrication in Bulk Silicon Brings 3D Integrated Photonics Step Closer
  Jul 23, 2024
• Quandela, Welinq Partner on Quantum Interconnects for Photonic Computing
  Jul 23, 2024
• Sivers Semiconductors Appoints President and CEO
  Jul 22, 2024
• OptoGPT to Enhance Optical Component Design
  Jul 22, 2024
• Affordable Light-Sheet Microscope Could Spur Biomedical Exploration
  Jul 22, 2024
• TRUMPF and SiMa.ai Partner on AI Lasers
  Jul 19, 2024
• Mahr Group Acquires OptoSurf GmbH: Week in Brief: 7/19/24
  Jul 19, 2024